How to Survive a DEA Audit or FIND=FINE - Webinar by GlobalCompliancePanel 2010
September 30, 2010(Ended)
Online Webinar
This training entitled "How to Survive a DEA Audi or FIND=FINE" will cover all the record-keeping and security requirements that a DEA registered pharmacy must comply with when handling controlled substances and regulated chemicals. It covers all elements of what occurs during an unannounced DEA Diversion inspection and the auditing of all controlled substances and regulated chemicals. Why should you attend: When DEA Diversion personnel conducts an unannounced inspection of a pharmacy to perform an audit, they generally do not inform the DEA registrant on what steps will be taken during the inspection. In some cases, the pharmacist is not aware of what information they will need until they are asked by the investigators. In so many cases, the lack of record-keeping and security requirements will lead to some type of actions from an administrative violations to a civil action that may result in the pharmacy paying thousands of dollars to settle any allegation that were uncovered by DEA personnel.
This presentation will cover all the elements of a DEA inspection and all the record-keeping and security requirements that are expected during that unannounced inspection and will place you in a better situation to understand all the areas of the inspection. By following the outline, you can prepare your pharmacy for that unannounced inspection.
Areas Covered in the Session: Class participants will familiarize themselves with the federal laws and regulations pertaining to the dispensing of controlled substances in the form of a prescription. The presentation will:
- Discuss the types of criminal and civil actions that can be imposed by a federal prosecutor’s office on a pharmacy pertaining to the purchase, sale, transfer, dispensing, destruction and theft or loss of Schedules II through V controlled substances.
- Identify the steps taken by Drug Enforcement Administration (DEA) and their Office of Diversion Control in enforcing federal laws and DEA regulations.
- Discuss DEA requirements pertaining to: Biennial Inventory; Executed or Voided DEA Form 222 and Invoices; Power of Attorney; Theft and Loss; Drug Destruction; and the Storage of Prescriptions.
- Review DEA requirements pertaining to the writing of a controlled substance prescription by a physician and the filling of that prescription by a pharmacy. This includes electronic prescriptions, a 90-day supply of a Schedule II drug, and prescriptions written for opioid dependency patients.
- Identify DEA requirements pertaining to: Alarm Systems; Pharmacy Security; Hiring of Employees; Proper Drug Disposal; Prevention of Thefts and Losses; and other security issues.
Who Will Benefit: All pharmacist and pharmacy technicians who work in retail or hospital pharmacy setting and dispense Schedules II through V controlled substances to a patient in the form of a prescription that is written by a physician for legitimate medical reasons.
Prices *
245 US Dollar
Exhibition
No exhibition
Organization
Categories
Concurrent events
- Development, Management, and Operation of an Effective Supplier and Internal Auditing System - Webinar by GlobalCompliancePanel 2010
- Managing Product Medical Device Recall Efficiently and Effectively - Webinar by GlobalCompliancePanel 2010
- Best Practices for Managing FDA Investigators and Handling FDA 483 Observations
- Project Management Certification Study Group - Information Year 2010
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Business Seminars can Change your Outlook
- Medical Seminars for All in the Field
- Power plant operations & maintenance 2011 - Surcharged energy expectations (An editorial Report posted by JFPS Group)
- A Study of clinical profile and treatment outcome of DOTS regime in 250 pulmonary and extra pulmonary patients in Hamidia hospital ,Bhopal in the year 2011
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Estimation of Serum Leptin Levels in Patients with chronic hepatitis C (CHC)






